The first functional “bioficial” thyroid to be implanted in a human being will be completed by 2015 according to a recent release by Skolkovo, Russia based 3D Bioprinting Solutions. The news, which was first reported by the Russia Today online version has been confirmed directly to 3DPI by 3D Bioprinting Solution’s Marketing Manager Julia Smirnova.
Laura Bosworth wants to 3D print breast nipples on demand. The CEO of the Texas startup TeVido Biodevices is betting on a future in which survivors of breast cancer who have undergone mastectomies will be able to order up new breasts printed from their own living cells.
3D bioprinting – often referred to as “bioprinting” – is the process that allows scientists to generate and assemble cellular layers to form organic tissues. While scientist already use 3D printing process to create custom implants and prosthesis in polymeric or metal materials, bioprinting implies the use of organic materials, thus the tissues and organs that are created are considered to be both biological and artificial. Or “bioficial”.
3d Bioprinting Solutions is a great Russian science company based in Moscow.
Here you can see 3d visualization of the first Russian bioprinter and it's basic principles of work. The speed of the machinery can be faster than in the reality.
3d Bioprinting Solutions is a great Russian science company based in Moscow.
This is the second part of my project.
In this animations you can see the macro version of the bioprinting process.
Skolkovo Innovation Center is één van de meest in het oog springende pogingen om de Russische economie te diversificeren en te moderniseren. Innovatiestad Skolkovo brengt wetenschappers, bedrijfsleven en investeerders samen met als doel om innovaties tot stand te brengen, onder andere in een biomedisch cluster. Sinds de start in 2010 zijn ruim 215 innovatieve bedrijven samen, die actief zijn in het ontwikkelen van innovatieve medicijnen, producten voor medische diagnostiek en behandeling, nieuwe bio-compatible materialen en cell technologies.
As many of you will know, the 3D printing revolution is quickly expanding into new technological avenues that many people would not quickly associate with additive manufacturing. Perhaps the biggest challenge among them is 3D bioprinting, or the creation of cell tissue. Tests have shown bioprinting to be potentially capable of producing blood vessels, vascular networks, and other transplantable tissues, while some scientists are even dreaming of 3D printed hamburgers.
While there are a number of areas in the field of 3D printing technology that haven't yet been mastered, one the biggest challenges currently around must be bioprinting. To be sure, there are a number of 3D bioprinters out there already – only this week we reported 3Dynamic Systems and their two bioprinters – but there is still a long way to go before this technology becomes affordable, available and commercially interesting.
A printable organ is an artificially constructed device designed for organ replacement, produced using 3D printing techniques. The primary purpose of printable organs is in transplantation. Research is currently being conducted on artificial heart, kidney, and liver structures, as well as other major organs. For more complicated organs, such as the heart, smaller constructs such as heart valves have also been the subject of research. Some printed organs have already reached clinical implementation, and primarily include hollow structures such as the bladder, as well as vascular structures such as urine tubes.
Russia's 3D Bioprinting Solutions laboratory, the first facility to successfully print a mouse's thyroid gland, is getting ready to transplant artificial organs to living mice. If successful, the experiment could pave the way for the production of 3D-printed human glands.
